![]() |
By Peter Rost (about the author) Page 2 of 2 page(s)
2) Minimize the efficacy of letrozole by slamming their trial.
3) Imply that Arimidex efficacy is better than letrozole WITHOUT ANY COMPARATIVE DATA. Remember, we're talking CANCER patients here, not restless leg syndrome.
And we're talking about a company which has been forced by the United States Department of Health and Human Services to follow certain procedures and ethics, based on their past crimes.
Basically through the documents and slide presentations published earlier here, we've now shown that AstraZeneca sales, marketing and training have a coordinated campaign to sell against letrozole.
WITHOUT ANY COMPARATIVE DATA.
The OIG has been notified and will have to determine if this violates AstraZeneca's policy, which by definition also would be a violation of AZ's Corporate Integrity Agreement.
For earlier coverage of this story, click links for CNBC television and print news media.
1 | 2
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
Contact Author |
Contact Editor |
View Authors' Articles |
| 1 comments |
Want to post your own comment on this Article?
|
||||
Tell a Friend:
|
Copyright © 2002-2009, OpEdNews |